PRINCETON, N.J. -- Derma Sciences, Inc., a manufacturer and full line supplier of wound and skin care products, today announced that the company has entered into a multi-year agreement with Smith & Nephew plc to manufacture a line of S&N-brand wound dressing for sale around the world. The company expects first year revenue from the agreement of approximately $1 million.
"Our company is proud to be working with market-leader Smith & Nephew," said Edward J. Quilty, president and CEO. "Our selection speaks to Derma Sciences' commitment to quality products, and reflects the confidence and belief Smith & Nephew has in our company. We look forward to working closely with them and for the opportunity to work on additional projects in the near future."
Source: Derma Sciences, Inc.
Â
Â
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.